Results 61 to 70 of about 4,386 (137)
Perspectives on Sexual and Reproductive Health, EarlyView.ABSTRACT Introduction Medication abortion use is increasing in the United States following policy and legal changes since 2021. Multiple service options exist within and outside of the US health system, but limited evidence addresses individuals' preferences for medication abortion services and support.
Hannah H. Leslie +4 more
wiley +1 more source
Journal of Mid-Life Health, 2018 Background: Leiomyomata causing symptoms have a deleterious effect on the health of women during reproductive age. Mifepristone, a progesterone antagonist was studied for reduction of symptoms in leiomyomata in perimenopausal women. Material and Methods:
Deepti Jain
doaj +1 more source
, 2009 Objectives: To determine the acceptability, efficacy and costs of medical termination of pregnancy (MTOP) compared with surgical termination of pregnancy (STOP) at less than 14 weeks’ gestation, and to understand women’s decision-making processes and ...
Kelly, T. +18 more
core +1 more source
Mifepristone With Buccal Misoprostol for Medical Abortion [PDF]
, 2015 ObjectiveTo summarize clinical outcomes and adverse effects of medical abortion regimens consisting of mifepristone followed by buccal misoprostol in pregnancies through 70 days of gestation.Data sourcesWe used PubMed, ClinicalTrials.gov, and reference ...
Creinin, Mitchell D, Chen, Melissa J
core +1 more source
MedComm, Volume 7, Issue 10, October 2026.Polyploid giant cancer cells (PGCCs) arise in response to stress and play a critical role in therapy resistance and tumor dormancy. These cells can evade conventional treatments and later contribute to cancer relapse by generating progeny through nonmitotic, amitotic mechanisms.
Silvia Guil‐Luna +3 more
wiley +1 more source
Abortion—A brief description of the evolution of methods
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 10, Page 1898-1903, October 2026.Termination of pregnancy is not a “modern” societal issue, but one that has been afforded to women, albeit with varying degrees of success, over many centuries. Methods have evolved which have increased the availability, effectiveness, and safety of abortion, while substantially reducing associated morbidity.
Laura Slade, Andrea Deussen, Jodie Dodd
wiley +1 more source
British Abortion Law: Speaking from the Past to Govern the Future [PDF]
, 2016 This paper analyses the poor alignment of the aging statutory framework and modern understandings of medical best practice in the context of abortion services.
Sheldon, S., Sheldon, Sally
core +1 more source
Clinical Endocrinology, Volume 105, Issue 4, Page 452-463, October 2026.ABSTRACT Objective Evaluate the effects of osilodrostat short‐ and long‐term treatment on health‐related quality of life (HRQoL) in Cushing's disease. Design LINC 3 and LINC 4 studies (pooled analysis). Patients 185 patients (mean baseline total scores: Cushing's Quality of Life [CushingQoL], 44.0; Beck Depression Inventory II [BDI‐II], 15.6; EuroQol ...
John Newell‐Price +6 more
wiley +1 more source
Women's Health ReportsBackground: About 25% of pregnancies end in early miscarriage or abortion annually in the United States. While mifepristone is part of the most effective medication regimen for miscarriage and abortion, regulatory burdens and legal restrictions limit its
Emily Newton-Hoe +4 more
doaj +1 more source
The immunological effect of Galectin-9/TIM-3 pathway after low dose Mifepristone treatment in mice at 14.5 day of pregnancy. [PDF]
PLoS ONE, 2018 The abortifacient Mifepristone (RU486) has proven to be a safe, effective, acceptable option for millions of women seeking abortion during the first and second trimester of pregnancy although its precise mechanism of action is not well understood.
Adrienn Lajko +3 more
doaj +1 more source